Study programme 2015 - 2016
Activité d'apprentissage à la Faculty of Medicine and Pharmacy
CodeLecturer(s)Associate Lecturer(s)Subsitute Lecturer(s) et other(s)
M-BIMO-003
  • COPPEE Frédérique
      Language
      of instruction
      Language
      of assessment
      HT(*) HTPE(*) HTPS(*) HR(*) HD(*) Term
      FrançaisFrançais1515000Q1

      Contents

      Impact of a mutation on the phenotype. Loss and gain of function, recessive and dominant phenotypes, dominant negative, haploinsufficiency. Gene therapy: ex-vivo and in vivo strategies, target cells, stem cells. Episomal or integrative therapeutic genes in target cells. Viral and non-viral vectors: advantages and disadvantages. Antisense strategies, siRNA, miRNA, antisense oligonucleotides, ribozymes, aptamers, RNA decoys, trans splicing, mutation corrections, zinc-finger and TALE nucleases, CRISPR/Cas9. Examples of gene therapies on different pathologies and their successes.

      Required Learning Resources/Tools

      Not applicable

      Recommended Learning Resources/Tools

      informations complémentaires sur la plateforme Moodle

      Other Recommended Reading

      Not applicable

      Mode of delivery

      • Face to face

      Term 1 Assessment - type

      • Presentation and works

      Term 1 Assessment - comments

      Not applicable

      Term 2 Assessment - type

      • N/A

      Term 2 Assessment - comments

      Not applicable

      Term 3 Assessment - type

      • Presentation and works

      Term 3 Assessment - comments

      Not applicable

      Resit Assessment - Term 1 (B1BA1) - Comments

      Not applicable

      Type of Teaching Activity/Activities

      • Cours (cours magistraux; conférences)
      • Exercices dirigés / utilisation de logiciels / démonstrations
      UE : Programme component - AA : Teaching activity
      (*) HT : Hours of theory - HTPE : Hours of in-class exercices - HTPS : hours of practical work - HD : HMiscellaneous time - HR : Hours of remedial classes. - Per. (Period), Y=Year, Q1=1st term et Q2=2nd term